A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from
Identificadores
Identificadores
Fecha de publicación
2015Título de revista
LANCET
Tipo de contenido
Artigo